These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30905798)

  • 1. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
    Barbieri JS; Choi JK; James WD; Margolis DJ
    J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 3. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
    Barbieri JS; Choi JK; Mitra N; Margolis DJ
    J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians.
    Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Watanabe-Ono A; Suga H; Inoue K; Gonda K; Yoshimura K
    Aesthetic Plast Surg; 2006; 30(6):689-94. PubMed ID: 17077951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Trial Design for a Comparative Effectiveness Study of Spironolactone versus Oral Antibiotics for Women With Acne: A Delphi Consensus Panel.
    Barbieri JS; Margolis DJ
    J Drugs Dermatol; 2020 Dec; 19(12):1238-1239. PubMed ID: 33346508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
    Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
    Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial.
    Kelidari HR; Saeedi M; Hajheydari Z; Akbari J; Morteza-Semnani K; Akhtari J; Valizadeh H; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Oct; 146():47-53. PubMed ID: 27248464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.
    Barbieri JS; Margolis DJ; Mostaghimi A
    JAMA Dermatol; 2021 Mar; 157(3):296-300. PubMed ID: 33502462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
    Turowski CB; James WD
    Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis from spironolactone.
    Corazza M; Strumìa R; Lombardi AR; Virgili A
    Contact Dermatitis; 1996 Dec; 35(6):365-6. PubMed ID: 9118635
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris.
    Guzman AK; Barbieri JS
    J Am Acad Dermatol; 2021 Apr; 84(4):1119-1121. PubMed ID: 32561369
    [No Abstract]   [Full Text] [Related]  

  • 15. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
    Grandhi R; Alikhan A
    Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinological evaluation and hormonal therapy for women with difficult acne.
    Thiboutot DM
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():57-61. PubMed ID: 11843236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
    Poinas A; Lemoigne M; Le Naour S; Nguyen JM; Schirr-Bonnans S; Riche VP; Vrignaud F; Machet L; Claudel JP; Leccia MT; Hainaut E; Beneton N; Dert C; Boisrobert A; Flet L; Chiffoleau A; Corvec S; Khammari A; Dréno B
    Trials; 2020 Jun; 21(1):571. PubMed ID: 32586344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients.
    Shaw JC
    J Am Acad Dermatol; 2000 Sep; 43(3):498-502. PubMed ID: 10954662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of spironolactone therapy in women with acne.
    Lubbos HG; Hasinski S; Rose LI; Pollock J
    Arch Dermatol; 1998 Sep; 134(9):1162-3. PubMed ID: 9762041
    [No Abstract]   [Full Text] [Related]  

  • 20. Spironolactone in adolescent acne vulgaris.
    Dhurat R; Shukla D; Lim RK; Wambier CG; Goren A
    Dermatol Ther; 2021 Jan; 34(1):e14680. PubMed ID: 33326148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.